The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

LONDON - Cardiogeni PLC (AQSE: CGNI), a UK-based biotech firm focused on developing treatments for heart failure, announced today the official start of trading of its shares on the Aquis Stock ...

(Alliance News) - The struggling public market in London got a small, but much-needed, vote of confidence on Friday, as Cardiogeni PLC started trading on Aquis Stock Exchange, while RC Fornax PLC ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will ...

The Driver and Vehicle Licensing Agency (DVLA) is warning drivers about various medical conditions that could affect their ability to drive. It urges individuals to declare any listed conditions to ...

However, if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments to desperate patients looking for cures of intractable diseases and ...